Skip to main content
Log in

Sacubitril/valsartan not cost effective for HF in Thailand

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. 2017 Thai baht

  2. 2017 US dollars

Reference

  • Krittayaphong R, et al. Cost-Effectiveness Analysis of Sacubitril-Valsartan Compared with Enalapril in Patients with Heart Failure with Reduced Ejection Fraction in Thailand. American Journal of Cardiovascular Drugs : 12 Jun 2018. Available from: URL: http://doi.org/10.1007/s40256-018-0288-x

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sacubitril/valsartan not cost effective for HF in Thailand. PharmacoEcon Outcomes News 806, 25 (2018). https://doi.org/10.1007/s40274-018-5068-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-018-5068-y

Navigation